8 completed. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
Follow Calcium supplement: new trials by email Literature Review of Calcium supplement trials Research Report on Calcium supplement
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate the Tolerability and Efficacy of Microencapsulated Calcium Carbonate Calcium supplement - Hypocalcemia; Dietary | Phase 3 | Completed | Instituto Palacios | 208 | 2018-06-15 | 2019-04-08 |
| The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA Teriparatide, Placebo, Calcium supplement - Unstable Intertrochanteric Fracture, Pertrochanteric Fracture of Femur, Closed | Phase 3 | Completed | King Chulalongkorn Memorial Hospital | 50 | 2017-05-17 | 2025-01-15 |
| Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome Yasmin, Calver, Placebo 1 - Premenstrual Syndrome | Phase 3 | Completed | Beni-Suef University | 210 | 2014-05-01 | 2015-08-11 |
| A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors Denosumab 70 mg/mL, Zoledronic acid 4 mg, Placebo IV - Fractures, Bone | Phase 3 | Completed | GlaxoSmithKline | 487 | 2013-08-01 | 2017-01-16 |
| Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall Safety in Postmenopausal Women (MK-0822-031) Odanacatib, Placebo, Vitamin D3 - Osteoporosis | Phase 3 | Completed | Merck Sharp & Dohme LLC | 214 | 2008-10-02 | 2018-08-27 |
| Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases zoledronic acid, placebo, androgen deprivation therapy - Metastatic Cancer, Prostate Cancer | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 645 | 2004-01-01 | 2020-05-12 |
| Supplemental Calcium in Overweight People Calcium supplement, Placebo - Obesity | Phase 3 | Completed | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 540 | 2002-02-06 | 2019-11-22 |
| Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis teriparatide, Placebo, Calcium Supplement - Osteoporosis, Postmenopausal | Phase 3 | Completed | Eli Lilly and Company | 1637 | 1996-08-01 | 2008-05-01 |
Body Weight (1) · Fractures, Bone (1) · Hypertension (1) · Hypocalcemia (1) · Neoplasm Metastasis (1) · Obesity (1) · Osteoporosis (1) · Osteoporosis, Postmenopausal (1) · Premenstrual Syndrome (1) · Prostatic Neoplasms (1) · Weight Gain (1)
Alliance for Clinical Trials in Oncology (1) · Beni-Suef University (1) · Eli Lilly and Company (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · GlaxoSmithKline (1) · Instituto Palacios (1) · King Chulalongkorn Memorial Hospital (1) · Merck Sharp & Dohme LLC (1)
United States (3) · Canada (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · China (1) · Czechia (1) · Denmark (1) · Egypt (1) · Finland (1) · Hungary (1) · Israel (1) · Italy (1) · Netherlands (1)
Abdelgany M Hassan, Lecturer (1) · Jack A Yanovski, M.D. (1) · Matthew R. Smith, MD, PhD (1) · Nesreen A Shehata, Lecturer (1) · Prof.Dr.Aree Tanavalee, M.D. (1) · Santiago Palacios, PI (1)
PMID 19250060, PMID 19528561, PMID 23337728, PMID 24590644, PMID 24898537, PMID 26808666, PMID 29718281, PMID 30937899, PMID 33270906, PMID 38271099
U10CA031946 (1)